Episode 136 - Philippe Chambon - CEO & Co-Founder EG427

In this episode of The BioHub Podcast, Max sits down with Dr. Philippe Chambon, CEO and Co-Founder of EG 427.

After more than 30 years in pharma and venture capital — raising over $1 billion to back life science companies — Philippe has made the move from investor to operator, now leading EG 427.

The company is pioneering a new approach to neurological disease with pinpoint DNA medicine, designed for precise and durable delivery.

In this conversation, Philippe shares his journey into the CEO seat, the inspiration behind EG 427, and why he believes Europe — and France in particular — are entering a new era for biotech innovation.